Evidence map›Paper›PMID 34249505›Full record

ArticlePeerJ2021

Biosynthesized selenium nanoparticles: characterization, antimicrobial, and antibiofilm activity against

Sanjay Miglani, Nobuyuki Tani-Ishii

Abstract read
In one paragraph

Article in PeerJ, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Heliyon · 2023
    Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Investigation of the Antibacterial and Antibiofilm Activity of Selenium Nanoparticles againstThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sanjay MiglaniDepartment of Conservative Dentistry & Endodontics, Faculty of Dentistry, Jamia Millia Islamia University, Delhi, India.ORCID 0000-0003-1981-0516
Nobuyuki Tani-IshiiDepartment of Pulp Biology and Endodontics, Graduate School of Dentistry, Kanagawa Dental College, Yokosuka, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundControl over microbial growth is a crucial factor in determining the success of endodontic therapy. MATERIALS AND

methodsSelenium nanoparticles were derived using fresh guava leaves (

resultsAntibacterial and antibiofilm efficacy of all tested solutions showed superior antibacterial and antibiofilm efficacy when compared to the control group. Overall, SeNPs (Group II) was the most effective against

conclusionBiogenically produced SeNPs emerged as a novel antibacterial and antibiofilm agent against

Indexed as

Calcium hydroxideChlorhexidine gluconateDentistryEndodonticsEnterococcus faecalisSelenium nanoparticlesSodium hypochlorite

Identifiers

PMID34249505
PMCPMC8254471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.